Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications
Acta pharmacologica Sinica, 2021-11, Vol.42 (11), p.1725-1741 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to CPS and SIMM. ;The Author(s), under exclusive licence to CPS and SIMM 2021. ;The Author(s), under exclusive licence to CPS and SIMM 2021 ;ISSN: 1671-4083 ;EISSN: 1745-7254 ;DOI: 10.1038/s41401-020-00584-2 ;PMID: 33574569
Full text available